Skip to search formSkip to main contentSkip to account menu

Travatan

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Purpose: To assess ocular surface changes in participants using latanoprost with benzalkonium chloride (Xalatan) and travoprost… 
2016
2016
Objective: To assess symptoms of ocular surface disease (OSD) in patients treated with a BAK-preserved Xalatan (Latanoprost) to… 
2008
2008
AbstractBackground Adherence to long-term intraocular pressure (IOP) lowering medication is poor in patients with glaucoma, which… 
2007
2007
Travoprost Z (Travatan® Z) ophthalmic solution has recently been approved for the reduction of elevated intraocular pressure (IOP… 
2006
2006
The aim of investigation was to study the effect of travatan on intraocular pressure (IOP) in patients with primary open-angle… 
2004
2004
The prostamide bimatoprost (Lumigan®, Allergan Inc.) has been proven highly effective as monotherapy, adjunctive, and replacement…